Gerta Kobeci-Cami
Bath, ENG BA27AY, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Synthesis and evaluation of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors.
Journal: RSC medicinal chemistry
Published: August 01, 2025
Effects of the μ-opioid peptide and nociceptin/orphanin FQ peptide receptor agonist BU08028 on cocaine self-administration in male rhesus monkeys.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 31, 2025
OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects.
Journal: Behavioural pharmacology
Published: August 10, 2022
PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats.
Journal: Neuropharmacology
Published: January 11, 2022
COVID-19 and Parkinson's Disease: Shared Inflammatory Pathways Under Oxidative Stress.
Journal: Brain sciences
Published: September 22, 2020
OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 16, 2019
Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: November 06, 2018
Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile.
Journal: Frontiers in psychiatry
Published: April 26, 2018
BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
Journal: British journal of anaesthesia
Published: October 09, 2017
A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2016
Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
Journal: Pharmacological reports : PR
Published: August 24, 2016
Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Journal: European journal of pharmacology
Published: April 10, 2015
Last Updated: 09/26/2026